« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 9, Issue 9
, Pages 559-570
, September 2003
An epithelial target site in experimental graft-versus-host disease and cytokine-mediated cytotoxicity is defined by cytokeratin 15 expression
References
-
.
Cellular pathology of cutaneous graft-versus-host disease.
In:
Ferrara JLM, Deeg HI, Burakoff SJ editor. Graft-vs-Host Disease.: Immunology, Pathophysiology, and Treatment. New York, NY: Marcel Dekker; 1996;p. 291–313
- . Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease. J Invest Dermatol. 1996;107:377–383
- . Experimental induction and ultrastructural characterization of apoptosis in murine acute graft-versus-host disease. Arch Dermatol Res. 1997;289:389–398
- . Young rete ridge keratinocytes are preferred targets in cutaneous graft-vs-host disease. Am J Pathol. 1985;118:278–287
- . Stem cell regions in filiform papillae of tongue as targets of graft-vs-host disease. Transplantation. 1994;58:1273–1287
- . Novel expression of VCAM-1 (CD106) by squamous epithelium in experimental acute graft-versus-host disease. Am J Pathol. 2002;161:763–769
- . Parafollicular bulges, but not hair bulb keratinocytes, are attacked in graft-vs-host disease of human skin. Bone Marrow Transplant. 1994;14:411–413
- . Cytotoxic folliculitis in GVHD. J Cutan Pathol. 1990;18:309–314
- . Heterogeneity in epidermal basal keratinocytes (morphological and functional correlations). Science. 1982;215:1239–1241
- . Label-retaining cells reside in the bulge area of pilo-sebaceous unit (implications for follicular stem cells, hair cycle, and skin carcinogenesis). Cell. 1990;61:1329–1337
- . Identification and behavior of label-retaining cells in oral mucosa and skin. J Dent Res. 1981;60:1611–1620
- . Lethal graft-vs-host disease following bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med. 1978;148:1687–1698
- . Cutaneous acute graft-vs-host disease to minor histocompatibility antigens in a murine model (histologic analysis and correlation to clinical disease). J Invest Dermatol. 1986;86:371–375
- . Characterization of target injury of murine acute graft-vs-host disease directed to multiple minor histocompatibility antigens elicited by either CD4+ or CD8+ effector cells. Am J Pathol. 1991;138:983–990
- . Role of mast cells in early epithelial target cell injury in experimental acute graft-versus-host disease. J Invest Dermatol. 1994;102:451–461
-
.
The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells.
J Cell Sci. 1998;111:3179–3188
- Keratin 15 expression in stratified epithelia (downregulation in activated keratinocytes). J Invest Dermatol. 1999;112:362–369
- . Expression of the intermediate filament keratin gene, K15, in the basal cell layers of epithelia and the hair follicle. Exp Cell Res. 1998;244:448–459
- . Vβ spectratype analysis reveals heterogeneity of CD4+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease (correlations with epithelial tissue infiltrate). Biol Blood Marrow Transplant. 2001;7:2–13
- . Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease. J Immunol. 1998;161:41–48
- . T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide (implications for T cell allelic exclusion and antigen-specific repertoire). J Exp Med. 1991;174:1371–1383
-
.
A formaldehyde-glutaraldehyde fixative of high osmolarity for use in electron microscopy.
J Cell Biol. 1965;27:137A;
(abstr.)
- . Organ cultures of embryonic rat tongue support tongue and gustatory papilla morphogenesis in vitro without intact sensory ganglia. J Comp Neurol. 1997;377:324–340
- Migration of Langerhans cells and dermal dendritic cells in skin organ cultures (augmentation by TNFα and IL-1β). J Leukoc Biol. 1999;66:462–470
- . Induction of an activation antigen on postcapillary venular endothelium in human skin organ culture. J Immunol. 1987;139:1557–1562
- Peptide analogs which inhibit IgE-FcϵRIα interactions ameliorate the development of lethal graft-versus-host disease. Biol Blood Marrow Transplant. 1997;3:187–193
- . Fas ligand-deficient gld mice are more susceptible to graft-versus-host disease. Transplantation. 2000;70:184–191
- . Fas-deficient lpr mice are more susceptible to graft-versus-host disease. J Immunol. 2000;164:469–480
- T cells require TRAIL for optimal graft-versus-tumor activity. Nat Med. 2002;8:1433–1437
- Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8:575–581
- . Degranulation of human mast cells induces an endothelial antigen central to leukocyte adhesion. Proc Natl Acad Sci U S A. 1989;86:8972–8976
- . Human dermal mast cells contain and release tumor necrosis factor-α which induces endothelial leukocyte adhesion molecule-1. Proc Natl Acad Sci U S A. 1991;88:4220–4224
- . Features of T cells causing H-2 restricted lethal graft-versus-host disease across minor histocompatibility barriers. J Exp Med. 1982;155:872–883
- VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA/fibronectin binding site. Cell. 1990;60:577–584
- Ligand-induced adhesion to activated endothelium and to vascular cell adhesion molecule-1 in lymphocytes transfected with the N-formyl peptide receptor. J Immunol. 1994;152:4026–4035
- . Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J Immunol. 1992;148:1985–1992
- . Are stem cells attacked in graft-versus-host-disease?. J Cutan Pathol. 1991;18:305–306
- . Epithelial stem cells, hair follicles and tumor formation. Recent Results Cancer Res. 1993;128:31–43
- . Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate (implications on epithelial stem cells). Cell. 1998;57:201–209
- . Suppression of keratin 15 expression by transforming growth factor β in vitro and by cutaneous injury in vivo. Exp Cell Res. 2000;254:80–90
- . Proliferation rates in epidermis of patients with graft-versus-host disease, non-specific inflammation and normal skin. Bone Marrow Transplant. 1992;10:27–31
- . Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs-host disease. J Exp Med. 1987;166:1280–1289
- . Role of tumor necrosis factor-α and graft-versus-host disease and graft-versus-leukemia responses. Biol Blood Marrow Transplant. 2003;9:292–303
- . Two TNF receptors. Immunol Today. 1992;13:151–153
- . High-dose proinflammatory cytokines induce apoptosis of hair bulb keratinocytes in vivo. Br J Dermatol. 2000;143:1036–1039
PII: S1083-8791(03)00288-X
doi: 10.1016/S1083-8791(03)00288-X
© 2003 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 9, Issue 9
, Pages 559-570
, September 2003
